ABION Inc. (KOSDAQ:203400)
South Korea · Delayed Price · Currency is KRW 676.00
-14.00 (-2.03%)
At close: Aug 14, 2026
ABION Market Cap
ABION has a market cap or net worth of 60.91 billion as of September 4, 2026. Its market cap has decreased by -66.60% in one year.
Market Cap
60.91B
Enterprise Value
56.22B
Revenue
939.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
676.00
ChartMarket Cap Chart
Since April 5, 2017, ABION's market cap has increased from 54.88B to 60.91B, an increase of 10.98%. That is a compound annual growth rate of 1.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 60.91B | -78.40% |
| Dec 30, 2025 | 282.02B | 40.69% |
| Dec 30, 2024 | 200.46B | 22.52% |
| Dec 28, 2023 | 163.61B | 29.00% |
| Dec 29, 2022 | 126.83B | -53.68% |
| Dec 30, 2021 | 273.81B | 220.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AriBioLab | 70.60B |
| Psomagen | 69.15B |
| ADBiotech | 68.45B |
| Naturalendo Tech | 67.88B |
| PanGen Biotech | 67.50B |
| J2KBIO | 63.50B |
| TegoScience | 59.09B |
| QuadMedicine | 58.10B |